Chemours (CC) Operating Income (2014 - 2026)

Chemours' Operating Income history runs 13 years deep, the most recent figure standing at $26.0 million for Q1 2026.

• In Q1 2026, Operating Income fell 50.94% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at -$90.0 million (down 134.88% YoY), while the FY2025 annual figure was -$58.0 million, down 363.64% from the prior year.
• Operating Income was $26.0 million for Q1 2026 at Chemours, up from -$5.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $304.0 million in Q1 2022 to a low of -$396.0 million in Q2 2023.
• Historically, Operating Income has averaged $47.6 million across 5 years, with a median of $53.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Operating Income tumbled 282.49% in 2023, then jumped 1116.67% in 2024.
• A 5-year view of Operating Income shows it stood at -$9.0 million in 2022, then surged by 33.33% to -$6.0 million in 2023, then surged by 1116.67% to $61.0 million in 2024, then sank by 108.2% to -$5.0 million in 2025, then jumped by 620.0% to $26.0 million in 2026.
• The last three Operating Income figures came in at $26.0 million (Q1 2026), -$5.0 million (Q4 2025), and $81.0 million (Q3 2025), per Business Quant data.